Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.

Literature DB >> 18563498

Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.

Cemal Nuri Ercin, Teoman Dogru, Ilker Tasci, Gokhan Erdem, Alper Sonmez.

Abstract

Entities: Disease

Mesh：

Substances：
Adipokines
Insulin

Year: 2008 PMID： 18563498 DOI： 10.1007/s11695-008-9585-9

Source DB: PubMed Journal: Obes Surg ISSN： 0960-8923 Impact factor: 4.129

× No keyword cloud information.

8 in total

Review 1. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa
Journal: Circulation Date: 2005-09-12 Impact factor: 29.690

2. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

Authors: Hyeong Jin Kim; Eun Seok Kang; Dae Jung Kim; So Hun Kim; Chul Woo Ahn; Bong Soo Cha; Moonsuk Nam; Choon Hee Chung; Kwan Woo Lee; Chung Mo Nam; Hyun Chul Lee
Journal: Clin Endocrinol (Oxf) Date: 2007-02 Impact factor: 3.478

3. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.

Authors: Mahmut I Yilmaz; Alper Sonmez; Kayser Caglar; Turgay Celik; Müjdat Yenicesu; Tayfun Eyileten; Cengizhan Acikel; Yusuf Oguz; Izzet Yavuz; Abdulgaffar Vural
Journal: Nephrology (Carlton) Date: 2007-04 Impact factor: 2.506

4. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

Authors: Teoman Dogru; Alper Sonmez; Ilker Tasci; Ergun Bozoglu; Mahmut Ilker Yilmaz; Halil Genc; Gokhan Erdem; Mahmut Gok; Necati Bingol; Selim Kilic; Taner Ozgurtas; Sezin Bingol
Journal: Diabetes Res Clin Pract Date: 2006-09-07 Impact factor: 5.602

1 in total

1. Combination drug treatment in patients with non-alcoholic fatty liver disease.

Authors: Theodosios D Filippatos; Moses S Elisaf
Journal: World J Hepatol Date: 2010-04-27

1 in total

Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.

Review 1. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

2. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

3. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.

4. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

5. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.

6. Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men.

Review 7. The effect of thiazolidinediones on adiponectin serum level: a meta-analysis.

8. Plasma apelin is lower in patients with elevated LDL-cholesterol.

1. Combination drug treatment in patients with non-alcoholic fatty liver disease.